Interview with Brandon Kao, nanotechnology start-up co-founder of Avisi Technologies – “Working on VisiPlate has presented me with different types of challenges that helped me gain a more general knowledge of product development”
Avisi, a trailblazing medical device company, is developing VisiPlate, a nanotechnology-enabled aqueous shunt designed to treat glaucoma. Working closely with ophthalmologists and experts, Avisi is committed to introducing a reliable, safe and effective solution for glaucoma patients.
“The Future of Entrepreneurship is Students.” Avisi Technologies entered the Y-Prize, which encourages students to find commercialization opportunities for Penn research, educated themselves about the nanoscale technology in question, and won the competition.
Recap of Avisi CEO’s Participation in Two Impactful Panels at LSI Emerging Medtech Summit Avisi Technologies returns to the Life Science Intelligence (LSI) stage with CEO Rui Jing Jiang participating in several panel discussions at the 2025 MedTech Summit. The panel discussions involved leadership and design strategies for achieving success within the MedTech industry. Life […]
